Presented at the 2011 European Multidisciplinary Cancer Conference; September 23–27, 2011; Stockholm, Sweden.
Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation
Article first published online: 14 JUN 2013
Copyright © 2013 American Cancer Society
Volume 119, Issue 16, pages 3043–3051, 15 August 2013
How to Cite
Kwak, E. L., Shapiro, G. I., Cohen, S. M., Becerra, C. R., Lenz, H.-J., Cheng, W.-F., Su, W.-C., Robohn, M., Le Maulf, F., Lobmeyer, M. T., Chand, V. K. and Iafrate, A. J. (2013), Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation. Cancer, 119: 3043–3051. doi: 10.1002/cncr.28120
ELK, VKC and AJI contributed to concept and design. ELK, H-JL, W-FC, W-CS, MR, FLM, MTL, VKC and AJI were involved in the collection and assembly of data. ELK, H-JL, W-FC, MR, FLM, MTL, VKC and AJI contributed to data analysis and interpretation. ELK, GIS, H-JL, MR, FLM, MTL, VKC and AJI were involved in manuscript writing. ELK, GIS, SMC, H-JL, CRB, W-FC, W-CS, MR, FLM, MTL, VKC and AJI gave final approval of manuscript. ELK, GIS, SMC, CRB, H-JL, and W-FC contributed to the provision of study materials or patients.
- Issue published online: 2 AUG 2013
- Article first published online: 14 JUN 2013
- Manuscript Accepted: 15 MAR 2013
- Manuscript Revised: 11 MAR 2013
- Manuscript Received: 17 JAN 2013
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
If your institution is a registered Wiley Online Library customer, you can log in under your institution's name to see our content. This access is provided by Shibboleth or Athens.
Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions.
Please note that there are currently a number of duplicate entries in the list of institutions. We are actively working on fixing this issue and apologize for any inconvenience caused.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.